@midlifegremlin.bsky.social
This midlife crap sucks. I'm to young to be this damn old.
Reposted
Dr: do you eat healthy?
Me: of course I eat the quinoas, the kales
Dr:
Me: the hummuses
Dr: I’m gonna put no
Me: ok
Me: of course I eat the quinoas, the kales
Dr:
Me: the hummuses
Dr: I’m gonna put no
Me: ok
December 11, 2024 at 12:49 PM
Dr: do you eat healthy?
Me: of course I eat the quinoas, the kales
Dr:
Me: the hummuses
Dr: I’m gonna put no
Me: ok
Me: of course I eat the quinoas, the kales
Dr:
Me: the hummuses
Dr: I’m gonna put no
Me: ok
Reposted
I’m trying to strike a healthy balance between being informed and being oblivious.
November 23, 2024 at 11:53 AM
I’m trying to strike a healthy balance between being informed and being oblivious.
Reposted
Reposted
The point of bringing in Hegseth, Gaetz and Gabbard is to burn it all to the ground. Senate: You must recognize this and stop it.
November 17, 2024 at 11:44 AM
The point of bringing in Hegseth, Gaetz and Gabbard is to burn it all to the ground. Senate: You must recognize this and stop it.
November 18, 2024 at 12:25 AM
Reposted
Reposted
Reposted
First day on here and no idea where to start. Just need someplace to not worry about ... everything.
November 18, 2024 at 12:01 AM
First day on here and no idea where to start. Just need someplace to not worry about ... everything.
Reposted
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
medicine.washu.edu
November 16, 2024 at 3:09 PM
Good morning, Bluesky. Today’s #GoodMorningNews: a trial at Washington University’s school of medicine has shown great results for a vaccine that would prevent recurrence for a particularly aggressive form of breast cancer. It’s a small trial, but 3 years later 16/18 participants remain cancer free